These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21764575)

  • 1. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
    Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
    J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
    Hoekstra M; Li Z; Kruijt JK; Van Eck M; Van Berkel TJ; Kuiper J
    J Hepatol; 2010 Feb; 52(2):244-51. PubMed ID: 20015565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis.
    Ahn J; Lee H; Chung CH; Ha T
    Biochem Biophys Res Commun; 2011 Nov; 414(4):664-9. PubMed ID: 21986524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.
    Lin X; Jia J; Du T; Li W; Wang X; Wei J; Lin X; Zeng H; Yao L; Chen X; Zhuang J; Weng J; Liu Y; Lin J; Wu Q; Wang W; Yao K; Xu K; Xiao D
    PLoS One; 2015; 10(3):e0118417. PubMed ID: 25799309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice.
    Hoekstra M; Lammers B; Out R; Li Z; Van Eck M; Van Berkel TJ
    Mol Pharm; 2009; 6(1):182-9. PubMed ID: 19183106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
    Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells.
    Doddapaneni R; Chawla YK; Das A; Kalra JK; Ghosh S; Chakraborti A
    J Cell Biochem; 2013 Jul; 114(7):1575-83. PubMed ID: 23334867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
    Esau C; Davis S; Murray SF; Yu XX; Pandey SK; Pear M; Watts L; Booten SL; Graham M; McKay R; Subramaniam A; Propp S; Lollo BA; Freier S; Bennett CF; Bhanot S; Monia BP
    Cell Metab; 2006 Feb; 3(2):87-98. PubMed ID: 16459310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
    Zheng L; Lv GC; Sheng J; Yang YD
    J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.
    Möbus S; Yang D; Yuan Q; Lüdtke TH; Balakrishnan A; Sgodda M; Rani B; Kispert A; Araúzo-Bravo MJ; Vogel A; Manns MP; Ott M; Cantz T; Sharma AD
    J Hepatol; 2015 Jan; 62(1):101-10. PubMed ID: 25135862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
    Morán-Salvador E; López-Parra M; García-Alonso V; Titos E; Martínez-Clemente M; González-Périz A; López-Vicario C; Barak Y; Arroyo V; Clària J
    FASEB J; 2011 Aug; 25(8):2538-50. PubMed ID: 21507897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
    Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
    Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.